Clinical Trial Update: Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)

View source ↗

Summary

This clinical trial update describes END-DM1, a Virginia Commonwealth University study to establish biomarkers and clinical endpoints for myotonic dystrophy typ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myotonic Dystrophy Type

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Myotonic Dystrophy 1, DM1 | Status: RECRUITING